Skip to main content
. 2022 Aug 5:10.1002/ptr.7580. Online ahead of print. doi: 10.1002/ptr.7580

FIGURE 3.

FIGURE 3

Structure of potential active products in the treatment of COVID‐19 through immunomodulation (a) EGCG, (b) astragalus polysaccharide, (c) caffeic acid, and (d) resveratrol